|
 |
| REVIEW ARTICLE |
|
|
|
| Year : 2011 | Volume
: 43
| Issue : 5 | Page : 502-506 |
| |
The functional role of the alpha-1 adrenergic receptors in cerebral blood flow regulation
Sushmita Purkayastha, Peter B Raven
Department of Integrative Physiology and the Cardiovascular Research Institute, University of North Texas Health Science Center, Fort Worth, Texas, 76017, USA
| Date of Submission | 04-Jun-2011 |
| Date of Decision | 11-May-2011 |
| Date of Acceptance | 01-Jul-2011 |
| Date of Web Publication | 15-Sep-2011 |
Correspondence Address:
Sushmita Purkayastha
Department of Integrative Physiology and the Cardiovascular Research Institute, University of North Texas Health Science Center, Fort Worth, Texas, 76017
USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7613.84950
Cerebral vasculature is richly innervated by the α-1 adrenergic receptors similar to that of the peripheral vasculature. However, the functional role of the α-1adrenergic receptors in cerebral blood flow (CBF) regulation is yet to be established. The traditional thinking being that during normotension and normocapnia sympathetic neural activity does not play a significant role in CBF regulation. Reports in the past have stated that catecholamines do not penetrate the blood brain barrier (BBB) and therefore only influence cerebral vessels from outside the BBB and hence, have a limited role in CBF regulation. However, with the advent of dynamic measurement techniques, beat-to-beat CBF assessment can be done during dynamic changes in arterial blood pressure. Several studies in the recent years have reported a functional role of the α-1adrenergic receptors in CBF regulation. This review focuses on the recent developments on the role of the sympathetic nervous system, specifically that of the α-1 adrenergic receptors in CBF regulation.
Keywords: Alpha-1 adrenergic receptors, cerebral autoregulation, cerebral blood flow
How to cite this article:
Purkayastha S, Raven PB. The functional role of the alpha-1 adrenergic receptors in cerebral blood flow regulation. Indian J Pharmacol 2011;43:502-6 |
How to cite this URL:
Purkayastha S, Raven PB. The functional role of the alpha-1 adrenergic receptors in cerebral blood flow regulation. Indian J Pharmacol [serial online] 2011 [cited 2023 Jun 9];43:502-6. Available from: https://www.ijp-online.com/text.asp?2011/43/5/502/84950 |
| » Introduction | |  |
Perivascular nerves have been identified in close proximity to smooth muscle layers in the cerebral vessel [1],[2],[3] and the density of innervations of cerebral resistance vessels have been reported to be similar to the mesenteric and/or the femoral arterial beds. [4],[5] Astrocytes and vascular cells in association with the perivascular neurons of autonomic origin constitute a functional unit to maintain the cerebral microenvironment homeostasis. [6] Animal studies have identified the cerebral arteries being richly innervated with sympathetic nerve fibers. [7],[8],[9] However, the role of autonomic neural control of the cerebral blood flow (CBF) regulation remains controversial. [10],[11],[12] CBF is maintained relatively constant despite physiological fluctuations in the cerebral perfusion pressure between ranges of 60 and 150 mmHg by intrinsic myogenic properties of cerebral autoregulation. [13] The current traditional thinking is that in the presence of normocapnia and normotension changes in sympathetic tone appear to have limited effects on CBF. [14],[15] Previously, studies have reported that the sympathetic nervous system has an insignificant role in CBF regulation in normal conditions; for example, sectioning of the sympathetic nerves in dogs resulted in no effect on CBF. [15] In addition, no difference in cerebral autoregulation was observed between intact and denervated cerebral hemispheres following unilateral sympathetic denervation. [16] Chronic sympathetic denervation in animal models did not influence cerebral autoregulation. [17] However, activation of the sympathetic nervous system on cerebral vessels is effective during hypertension, hypoxia, hypercapnia, and hemorrhagic states. [18] Furthermore, several investigators have identified a direct effect of sympathoexcitation on CBF in pathophysiological conditions. [19],[20] In addition, in primates, the blood flow to the brain through internal carotid and vertebral arteries was reduced by direct stimulation of the cervical and stellate ganglia of the sympathetic nerve fibers of the brain. [21] In humans, a decrease in middle cerebral artery blood velocity (MCA V) was reported during unilateral trigeminal ganglion stimulation. [22] There is also strong evidence that increases in sympathetically mediated vasoconstriction protects cerebral vessels from overperfusion during hypertension. For example, in an animal model of hypertension the breakdown of the blood brain barrier (BBB) in the cerebrum was prevented by electrically induced sympathetic stimulation. [23] Together these findings suggest a functional role of the sympathetic nervous system in CBF regulation. In addition, the exponential increase in sympathetic activity that occurs during heavy weightlifting exercise to maximum in healthy humans resulting in systolic blood pressure that exceeds 300 mmHg, extends the cerebral autoregulatory range above 150 mmHg, increases cerebrovascular tone and buffers the pulsatile increases in cerebral perfusion pressure, thereby protecting the brain. [24] In addition, the partial pressure of carbon dioxide in the arterial blood strongly regulates CBF, while other physiological factors involved in CBF regulation are partial pressure of oxygen in arterial blood, cerebral neural activity, and cerebral metabolism [25] [Figure 1]. | Figure 1: The physiological factors known to influence cerebral blood flow regulation. In addition to these factors, recent studies have emphasized the role of the sympathetic nervous system infl uencing cerebral blood flow. CBF = cerebral blood fl ow, CO2 = carbon dioxide, O2 = oxygen
Click here to view |
| » α-1 adrenergic receptors on the cerebral vasculature | | |
Similar to the systemic vasculature, cerebral vessels are richly innervated with sympathetic nerve fibers connected to α-1 adrenergic receptors that appear to be located on the cerebral arterioles. [14] Although the α-1 adrenergic receptors are the most abundant adrenergic receptors in the brain, their role in the central nervous system is not yet established. [26] The alpha-1 adrenergic receptors are postsynaptic and stimulatory in nature. [26] In the vascular smooth muscle cells, α-1 adrenergic receptors bind to norepinephrine (NE), or other sympathomimetic drugs, and through receptor coupling with its Gq-protein stimulate phospholipase C activity which then promotes hydrolysis of phosphatidylinositol bisphosphate producing inositol triphosphate and diacylglycerol. [27] These molecules act as second messengers mediating intracellular Ca 2+ release from non-mitochondrial pools and activate protein kinase C, which then leads to a cascade of events leading to activation of contractile proteins and vasoconstriction. [28] The densities of α-1 adrenergic receptors are reported to undergo a diurnal rhythm in the brain regions associated with entrainment to photoperiod demonstrated in animal models. [29] Though several animal models have been used, species difference in the anatomy of the cerebral circulation may lead to contradiction in the results. Recently, age of the animals were also reported to influence the results as sympathetic innervation density and constrictor response to NE in the brain were weak in juvenile rats when compared to mature animals. [30]
The adrenergic receptors are members of the G-protein-coupled receptor superfamily of membrane proteins. Based on evidence of α-1 adrenergic receptors heterogeneity, they are subdivided into α-1A, α-1B, and α-1D, with α-1A subtype having higher binding affinities to agonist, such as methoxamine and antagonist 5-methylurapidil. Overexpression of α-1B adrenergic receptors did not result in an increase in blood pressure and studies have reported that α-1B adrenergic receptor is not a significant player in mediating vasoconstriction. Studies have demonstrated α-1D adrenergic receptors to be involved in vascular smooth muscle contraction but less dominant than the α-1A adrenergic receptors. [26] In addition to mediating intracellular Ca 2+ release, the α-1 adrenergic receptors are also reported to activate Ca 2+ influx through voltage-dependent and independent calcium channels. [31] Apart from calcium mobilization, α-1 adrenergic receptors stimulate MAPK signaling pathways and significantly contribute to increased DNA synthesis and cell proliferation in human vascular smooth muscle cells. [32] α-1 adrenergic receptors are also localized in glial cells and may affect brain functions through non-neuronal mechanisms. [33] There are reports of polymorphisms in the α-1 adrenergic receptors, but have not yet been linked to functional consequences unlike members of the β-adrenergic receptors. [26]
| » Blood brain barrier permeability and cerebral blood flow regulation | | |
Reports in the past have stated "that vasoactive amines do not penetrate the blood brain barrier (BBB) and only influence cerebral resistance vessels from the outside." [34] Consequently, they concluded that "the sympathetic nerves do not effectively control the inner vascular smooth muscle of the cerebral vessels." However, Sandor [35] refuted the impermeability of the BBB and reported that the peripheral adrenergic neurons come in close contact with the smooth muscle layer of the cerebral vessels. The density of α-1 adrenergic receptors in different regions of cerebral vessels also varies among species, which led to the differences in results among several studies. [35] Although there are reports of impermeable tight junctions on the BBB in the capillary endothelium, the tight junctions of the BBB in the endothelium of brain arterioles and venules of the cerebral microvasculature are found to be leaky and subject to greater modulation [36] [Figure 2]. Furthermore, there are reductions in the tightness by rupture of the BBB with increases in arterial pressure, [23] free radical and interlukin-6 concentrations, [37] all of which are abundant during hyperadrenergic disease states. [38] In addition, circulating NE also stimulates IL-6 production. [39] Vasoactive substances, such as bradykinin and nitric oxide, also appear to increase permeability of the BBB through activation of second messenger pathways. [40] The resultant increase in permeability of the BBB is proposed to make the α-1 adrenergic receptors accessible to the circulating NE along with local release of NE from nerve endings within the brain. Mitchell et al,[41] have recently demonstrated NE spillover from the cerebral vasculature into the internal jugular vein and identified that NE spillover originates primarily from the cerebral vasculature outside the BBB, and that the lipophilic metabolite spillover originates from both sides of the BBB. In Mitchell et al.'s [41] findings, it was noted that pure autonomic failure patients had 77% lower brain NE spillover than found in the healthy subjects, indicating that the sympathetic neuron degeneration associated with pure autonomic failure limited the NE spillover. | Figure 2: The factors and conditions which are reported to modulate the blood brain barrier (BBB) and make it leaky or subject to rupture allowing circulation norepinephrine (NE) to access the alpha-1 adrenergic receptors located within the brain in addition to local release of NE in the brain. IL-6 = interlukin-6; BP = blood pressure; SNA = sympathetic neural activity
Click here to view |
| » Functional role of α-1 adrenergic receptors in cerebral blood flow regulation | | |
Moreover, evidence of functional α-1 adrenoreceptors was demonstrated by an increase in cerebral vascular conductance following an experimentally induced acute hypotension with bilateral thigh cuff occlusion/release technique designed to stimulate the sympathetic nerve activity. [11] The increase in cerebral vascular conductance was attenuated by selective α-1 adrenergic blockade (prazosin) reflecting a sympathetically mediated dynamic control of the cerebral vasculature. In addition, attenuation of sympathetically mediated vascular tone induced by spinal cord stimulation resulted in increases in CBF due to withdrawal of sympathetic activation of the α-1 adrenergic receptors. [22],[42] In healthy subjects, a reduction in cerebral tissue oxygenation was reported after infusion of NE. [43] These findings identify the presence of functional α-1 adrenoreceptors in the cerebral vasculature. Recently, Brassard et al.[44] demonstrated a decrease in cerebral tissue oxygenation at rest with a bolus injection of phenylephrine which was attenuated during light-intensity cycling exercise and abolished with high-intensity exercise-mediated increase in cerebral metabolism indicating the presence of "functional sympatholysis" [45] similar to that observed in the peripheral vasculature, where sympathetic activity is overridden by accumulation of local metabolites. [46] Critical closing pressure, an index of cerebral vascular tone, was also demonstrated to increase in relation to increases in sympathetic activity with increases in exercise intensity. [47] These data strongly indicate a functional role of the α-1 adrenergic receptor-mediated sympathetic nerve activity in the cerebral vasculature.
| » Measurement of static vs. dynamic changes in cerebral blood flow | | |
Static cerebral autoregulation (sCA) refers to the relative steady-state relationship between CBF and arterial blood pressure (ABP), characterized by a positive slope of 0.8% (often referred to as a plateau) increase in CBF/mmHg between the autoregulatory range of 60 to 150 mmHg ABP. [48],[49] Dynamic cerebral autoregulation (dCA) corresponds to the transient response of CBF to beat-to-beat fluctuations in ABP during acute changes in arterial pressure. [50],[51] Hence, dCA is important for rapidly adjusting the CBF to its steady-state flow, when challenged by acute changes in perfusion pressure. [25] The importance of dCA on sCA and its effect on oxygen delivery to the brain is at the forefront of current research in CBF regulation. [25] Historically, the predominant measurement technique for assessing sCA was the Kety-Schmidt technique using 133 Xenon, which required one to establish steady-state conditions for the measure to be valid. This process resulted in elimination of dynamic assessment of CBF resulting from transient changes in ABP. Therefore, the dynamic changes in CBF were undetected, resulting in a reported constant CBF. Consequently, the cerebral metabolic rate for oxygen during exercise has been reported as unchanged. [52] Furthermore, the jugular venous sampling required for the Kety-Schmidt method was compromised, because it is now known that the internal jugular vein is collapsed in the upright position. [53],[54] In the upright posture, venous drainage from the brain is dependent on the spinal veins of the vertebral plexus. [55],[56],[57] In addition, it is now known that cerebral activation is directly associated with increases in regional CBF and metabolism, as detected by positron emission tomography. [58] With the advent of dynamic noninvasive measurement techniques, such as transcranial Doppler (TCD) of MCA V changes and near infrared spectroscopic analysis of cerebral tissue oxygenation, the dynamic regulation of CBF by dCA, when ABP is rapidly changing, can be accomplished. Because of these techniques, there is a growing body of evidence identifying that increases in sympathetic neural activity result in local release of NE within the brain and circulating NE which can bind to the accessible α-1 adrenergic receptors on the smooth muscle of the cerebral arterioles and influence dCA and sCA. [43],[11] The MCA V obtained from TCD does not take into account the vessel diameter which could possibly be increased due to sympathetically mediated decrease in vessel diameter. However, during exercise, the MCA V increases in parallel with the internal carotid artery blood flow. [59],[60] This suggests that sympathetic modulation does not significantly alter the diameter of the MCA, and that sympathetic regulation of CBF occurs mainly in the cerebral resistance arterioles rather than in the large cerebral conductance arteries. It is reasonable to propose that if the diameter of the MCA decrease in response to sympathoexcitation, the MCA V would increase; in fact, the opposite occurs and conductance is decreased, indicating that sympathetic vasoconstriction of the cerebral vessels occurs at the small resistance arterioles.
| » Arterial baroreflex interaction with the cerebral vasculature | | |
Studies in the past were unable to identify any relationship between the cerebral vasculature and its response to carotid baroreceptor stimulation, [61],[62] despite cerebral arteries being richly innervated with sympathetic nerve fibers. [8],[63] However, a reduction in CBF was observed when sympathetic nerves were activated through sinoaortic deafferentation, a procedure that produces marked elevation of peripheral sympathetic tone and extreme hypertension. [15] Stimulation of the carotid baroreceptors of baboons decreased their CBF, while at the same time maintaining the cerebral inflow pressure. [64] Similar results were obtained in a human study where MCA V decreased during unilateral trigeminal ganglion stimulation. [22] Zhang et al.[65] have demonstrated that dCA is altered with ganglion blockade using trimethaphan and thus speculated a tonic control of the autonomic nervous system in beat-to-beat CBF regulation. Patients with idiopathic orthostatic intolerance exhibit an excessive decline in CBF upon orthostasis despite sustained systemic blood pressure. However, this decline in CBF was abolished with phentolamine blockade of the α-adrenoreceptors during head-up tilt. [19] β-1 adrenergic blockade during dynamic cycling exercise in healthy humans diminished cardiac output as well as MCA V. In addition, because stellate ganglion blockade eliminated the β-1 blockade-induced decreases in MCA V, it was concluded that the exercise pressor reflex-induced sympathoexcitation resulting from underperfused exercising muscle was the cause of the reduction in MCA V. [66] The decrease in MCA V is indicative of an augmentation of sympathetic-mediated vasoconstriction in the cerebral vessels. [67] During recovery from acute hypotension induced by an ischemic thigh cuff occlusion/release protocol, [68] sympathoexcitation was evident from the decrease in cerebral vascular conductance identified by the rate of regulation (RoR), quantifying cerebral autoregulation. The RoR was attenuated by α-1 adrenoreceptor blockade [11] indicating arterial baroreflex control of the cerebral circulation through the sympathetic nervous system. Therefore, we conclude that the arterial baroreflex-mediated alterations of sympathetic nervous system are crucial in the beat-to-beat regulation of CBF.
| » Conclusion | | |
There is evidence of the dynamic functional role of the α-1 adrenergic receptor control of sympathetic neural activity in the cerebral circulation. It appears that increases in sympathetic activity increases cerebral vascular tone and by interaction with the myogenic properties of the smooth muscle cells of the cerebral vessels results in cerebral vasoconstriction and enhanced CA. Therefore, the use of vasoconstrictor drugs to support a patients' ABP during hemorrhage, surgery, and emergency care medicine requires further evaluation.
| » References | | |
| 1. | Aronson H. Uber nerven und nervendigungen in der Pia Mater. Zeitschrift fur Medizinisce Wissenschaft 1890;28:594-5. 
|
| 2. | Benedikt M. Uber die innervation des plexus choriodeus inferioir. Virchows Archives fur Pathologie, Anatomie und Phyisiologie 1874;59:395-400.
|
| 3. | Willis T. Cerebri anatone, cui accesit nervorum, descriptio etusus. Flesher J, London, 1664.
|
| 4. | Rosenblum W, Chen M. Density of perivascular nerves on some cerebral and extracerebral blood vessels. Blood Vessels 1976;13:374-8.
[PUBMED] |
| 5. | Rosenblum WI. The "richness" of sympathetic innervation. A comparison of cerebral and extracerebral blood vessels. Stroke 1976;7:270-1.
[PUBMED] [FULLTEXT] |
| 6. | Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 2004;5:347-60.
[PUBMED] [FULLTEXT] |
| 7. | Edvinsson L. Neurogenic mechanisms in the cerebrovascular bed. Autonomic nerves, amine receptors and their effects on cerebral blood flow. Acta Physiol Scand Suppl 1975;427:1-35.
[PUBMED] |
| 8. | Nelson E, Rennels M. Innervation of intracranial arteries. Brain 1970;93:475-90.
[PUBMED] [FULLTEXT] |
| 9. | Nielsen KC, Owman C. Adrenergic innervation of pial arteries related to the circle of Willis in the cat. Brain Res 1967;6:773-6.
[PUBMED] [FULLTEXT] |
| 10. | Hamner JW, Tan CO, Lee K, Cohen MA, Taylor JA. Sympathetic control of the cerebral vasculature in humans. Stroke 2010;41:102-9.
[PUBMED] [FULLTEXT] |
| 11. | Ogoh S, Brothers RM, Eubank WL, Raven PB. Autonomic neural control of the cerebral vasculature: Acute hypotension. Stroke 2008;39:1979-87.
[PUBMED] [FULLTEXT] |
| 12. | Zhang R, Behbehani K, Levine BD. Dynamic pressure-flow relationship of the cerebral circulation during acute increase in arterial pressure. J Physiol 2009;587:2567-77.
[PUBMED] [FULLTEXT] |
| 13. | Lassen NA. Autoregulation of Cerebral Blood Flow. Circ Res 1964;15:SUPPL:201-4.
|
| 14. | Fitch W, MacKenzie ET, Harper AM. Effects of decreasing arterial blood pressure on cerebral blood flow in the baboon. Influence of the sympathetic nervous system. Circ Res 1975;37:550-7.
[PUBMED] [FULLTEXT] |
| 15. | Heistad DD, Marcus ML, Gross PM. Effects of sympathetic nerves on cerebral vessels in dog, cat, and monkey. Am J Physiol 1978;235:H544-52.
[PUBMED] [FULLTEXT] |
| 16. | Strandgaard S, MacKenzie ET, Sengupta D, Rowan JO, Lassen NA, Harper AM. Upper limit of autoregulation of cerebral blood flow in the baboon. Circ Res 1974;34:435-40.
[PUBMED] [FULLTEXT] |
| 17. | Eklof B, Ingvar DH, Kagstrom E, Olin T. Persistence of cerebral blood flow autoregulation following chronic bilateral cervical sympathectomy in the monkey. Acta Physiol Scand 1971;82:172-6.
|
| 18. | Busija DW, Heistad DD. Factors involved in the physiological regulation of the cerebral circulation. Rev Physiol Biochem Pharmacol 1984;101:161-211.
[PUBMED] |
| 19. | Jordan J, Shannon JR, Black BK, Paranjape SY, Barwise J, Robertson D. Raised cerebrovascular resistance in idiopathic orthostatic intolerance: evidence for sympathetic vasoconstriction. Hypertension 1998;32:699-704.
[PUBMED] [FULLTEXT] |
| 20. | Pearce WJ, D'Alecy LG. Hemorrhage-induced cerebral vasoconstriction in dogs. Stroke 1980;11:190-7.
[PUBMED] [FULLTEXT] |
| 21. | Meyer JS, Yoshida K, Sakamoto K. Autonomic control of cerebral blood flow measured by electromagnetic flowmeters. Neurology 1967;17:638-48.
[PUBMED] |
| 22. | Visocchi M, Cioni B, Pentimalli L, Meglio M. Increase of cerebral blood flow and improvement of brain motor control following spinal cord stimulation in ischemic spastic hemiparesis. Stereotact Funct Neurosurg 1994;62:103-7.
[PUBMED] |
| 23. | Bill A, Linder J. Sympathetic control of cerebral blood flow in acute arterial hypertension. Acta Physiol Scand 1976;96:114-21.
[PUBMED] |
| 24. | Ogoh S, Fadel PJ, Zhang R, Selmer C, Jans O, Secher NH, et al. Middle cerebral artery flow velocity and pulse pressure during dynamic exercise in humans. Am J Physiol Heart Circ Physiol 2005;288:H1526-31.
|
| 25. | Ogoh S, Ainslie PN. Regulatory mechanisms of cerebral blood flow during exercise: New concepts. Exerc Sport Sci Rev 2009;37:123-9.
[PUBMED] |
| 26. | Piascik MT, Perez DM. Alpha1-adrenergic receptors: New insights and directions. J Pharmacol Exp Ther 2001;298:403-10.
[PUBMED] [FULLTEXT] |
| 27. | Olesen J. The effect of intracarotid epinephrine, norepinephrine, and angiotensin on the regional cerebral blood flow in man. Neurology 1972;22:978-87.
[PUBMED] |
| 28. | Guimaraes S, Moura D. Vascular adrenoceptors: An update. Pharmacol Rev 2001;53:319-56.
|
| 29. | Weiland NG, Wise PM. Estrogen alters the diurnal rhythm of alpha 1-adrenergic receptor densities in selected brain regions. Endocrinology 1987;121:1751-8.
[PUBMED] [FULLTEXT] |
| 30. | Omar NM, Marshall JM. Age-related changes in the sympathetic innervation of cerebral vessels and in carotid vascular responses to norepinephrine in the rat: in vitro and in vivo studies. J Appl Physiol 2010;109:314-22.
[PUBMED] [FULLTEXT] |
| 31. | Minneman KP. Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+. Pharmacol Rev 1988;40:87-119.
[PUBMED] [FULLTEXT] |
| 32. | Hu ZW, Shi XY, Lin RZ, Chen J, Hoffman BB. alpha1-Adrenergic receptor stimulation of mitogenesis in human vascular smooth muscle cells: role of tyrosine protein kinases and calcium in activation of mitogen-activated protein kinase. J Pharmacol Exp Ther 1999;290:28-37.
[PUBMED] [FULLTEXT] |
| 33. | Kulik A, Haentzsch A, Luckermann M, Reichelt W, Ballanyi K. Neuron-glia signaling via alpha(1) adrenoceptor-mediated Ca(2+) release in Bergmann glial cells in situ. J Neurosci 1999;19:8401-8.
|
| 34. | Strandgaard S, Sigurdsson ST. Point:Counterpoint: Sympathetic activity does/does not influence cerebral blood flow. Counterpoint: Sympathetic nerve activity does not influence cerebral blood flow. J Appl Physiol 2008;105:1366-7; discussion 1367-8.
[PUBMED] |
| 35. | Sandor P. Nervous control of the cerebrovascular system: Doubts and facts. Neurochem Int 1999;35:237-59.
|
| 36. | Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006;7:41-53.
|
| 37. | Abbott NJ. Dynamics of CNS barriers: Evolution, differentiation, and modulation. Cell Mol Neurobiol 2005;25:5-23.
[PUBMED] [FULLTEXT] |
| 38. | Pedersen BK, Febbraio MA. Muscle as an endocrine organ: Focus on muscle-derived interleukin-6. Physiol Rev 2008;88:1379-406.
[PUBMED] [FULLTEXT] |
| 39. | von Patay B, Kurz B, Mentlein R. Effect of transmitters and co-transmitters of the sympathetic nervous system on interleukin-6 synthesis in thymic epithelial cells. Neuroimmunomodulation 1999;6:45-50.
[PUBMED] [FULLTEXT] |
| 40. | Mayhan WG. Regulation of blood-brain barrier permeability. Microcirculation 2001;8:89-104.
[PUBMED] [FULLTEXT] |
| 41. | Mitchell DA, Lambert G, Secher NH, Raven PB, van Lieshout J, Esler MD. Jugular venous overflow of noradrenaline from the brain: A neurochemical indicator of cerebrovascular sympathetic nerve activity in humans. J Physiol 2009;587:2589-97.
|
| 42. | Patel S, Huang DL, Sagher O. Sympathetic mechanisms in cerebral blood flow alterations induced by spinal cord stimulation. J Neurosurg 2003;99:754-61.
[PUBMED] [FULLTEXT] |
| 43. | Brassard P, Seifert T, Secher NH. Is cerebral oxygenation negatively affected by infusion of norepinephrine in healthy subjects? Br J Anaesth 2009;102:800-5.
[PUBMED] |
| 44. | Brassard P, Seifert T, Wissenberg M, Jensen PM, Hansen CK, Secher NH. Phenylephrine decreases frontal lobe oxygenation at rest but not during moderately intense exercise. J Appl Physiol 2010;108:1472-8.
[PUBMED] [FULLTEXT] |
| 45. | Remensnyder JP, Mitchell JH, Sarnoff SJ. Functional sympatholysis during muscular activity. Observations on influence of carotid sinus on oxygen uptake. Circ Res 1962;11:370-80.
[PUBMED] [FULLTEXT] |
| 46. | Keller DM, Fadel PJ, Ogoh S, Brothers RM, Hawkins M, Olivencia-Yurvati A, et al. Carotid baroreflex control of leg vasculature in exercising and non-exercising skeletal muscle in humans. J Physiol 2004;561:283-93.
[PUBMED] [FULLTEXT] |
| 47. | Ogoh S, Brothers RM, Jeschke M, Secher NH, Raven PB. Estimation of cerebral vascular tone during exercise; Evaluation by critical closing pressure in humans. Exp Physiol 2010;95:678-85.
[PUBMED] [FULLTEXT] |
| 48. | Heisted D, Kontos H. Handbook of Physiology. Peripheral Circulation and Organ Blood Flow, Part I. Washington, DC: American Physiological Society; 1983.
|
| 49. | Lucas SJ, Tzeng YC, Galvin SD, Thomas KN, Ogoh S, Ainslie PN. Influence of changes in blood pressure on cerebral perfusion and oxygenation. Hypertension 2010;55:698-705.
[PUBMED] [FULLTEXT] |
| 50. | Panerai RB. Cerebral autoregulation: From models to clinical applications. Cardiovasc Eng 2008;8:42-59.
[PUBMED] |
| 51. | Tiecks FP, Lam AM, Aaslid R, Newell DW. Comparison of static and dynamic cerebral autoregulation measurements. Stroke 1995;26:1014-9.
[PUBMED] [FULLTEXT] |
| 52. | Madsen PL, Sperling BK, Warming T, Schmidt JF, Secher NH, Wildschiodtz G, et al. Middle cerebral artery blood velocity and cerebral blood flow and O2 uptake during dynamic exercise. J Appl Physiol 1993;74:245-50.
|
| 53. | Dawson EA, Secher NH, Dalsgaard MK, Ogoh S, Yoshiga CC, Gonzalez-Alonso J, et al. Standing up to the challenge of standing: A siphon does not support cerebral blood flow in humans. Am J Physiol Regul Integr Comp Physiol 2004;287:R911-4.
|
| 54. | Gisolf J, van Lieshout JJ, van Heusden K, Pott F, Stok WJ, Karemaker JM. Human cerebral venous outflow pathway depends on posture and central venous pressure. J Physiol 2004;560:317-27.
[PUBMED] [FULLTEXT] |
| 55. | Alperin N, Lee SH, Sivaramakrishnan A, Hushek SG. Quantifying the effect of posture on intracranial physiology in humans by MRI flow studies. J Magn Reson Imaging 2005;22:591-6.
[PUBMED] [FULLTEXT] |
| 56. | Cirovic S, Walsh C, Fraser WD, Gulino A. The effect of posture and positive pressure breathing on the hemodynamics of the internal jugular vein. Aviat Space Environ Med 2003;74:125-31.
[PUBMED] |
| 57. | Valdueza JM, von Munster T, Hoffman O, Schreiber S, Einhaupl KM. Postural dependency of the cerebral venous outflow. Lancet 2000;355:200-1.
|
| 58. | Secher NH, Seifert T, Van Lieshout JJ. Cerebral blood flow and metabolism during exercise: implications for fatigue. J Appl Physiol 2008;104:306-14.
[PUBMED] [FULLTEXT] |
| 59. | Hellstrom G, Fischer-Colbrie W, Wahlgren NG, Jogestrand T. Carotid artery blood flow and middle cerebral artery blood flow velocity during physical exercise. J Appl Physiol 1996;81:413-8.
|
| 60. | Huang SY, Sun S, Droma T, Zhuang J, Tao JX, McCullough RG, et al. Internal carotid arterial flow velocity during exercise in Tibetan and Han residents of Lhasa (3,658 m). J Appl Physiol 1992;73:2638-42.
[PUBMED] [FULLTEXT] |
| 61. | Heistad DD, Marcus ML, Said SI, Gross PM. Effect of acetylcholine and vasoactive intestinal peptide on cerebral blood flow. Am J Physiol 1980;239:H73-80.
[PUBMED] [FULLTEXT] |
| 62. | Rapela CE, Green HD, Denison AB Jr. Baroreceptor reflexes and autorregulation of cerebral blood flow in the dog. Circ Res 1967;21:559-68.
[PUBMED] [FULLTEXT] |
| 63. | Edvinsson L. Sympathetic control of cerebral circulation. Trends Neurosci 1982;5:425-9.
|
| 64. | Ponte J, Purves MJ. The role of the carotid body chemoreceptors and carotid sinus baroreceptors in the control of cerebral blood vessels. J Physiol 1974;237:315-40.
[PUBMED] [FULLTEXT] |
| 65. | Zhang R, Zuckerman JH, Iwasaki K, Wilson TE, Crandall CG, Levine BD. Autonomic neural control of dynamic cerebral autoregulation in humans. Circulation 2002;106:1814-20.
[PUBMED] [FULLTEXT] |
| 66. | Ide K, Boushel R, Sorensen HM, Fernandes A, Cai Y, Pott F, et al. Middle cerebral artery blood velocity during exercise with beta-1 adrenergic and unilateral stellate ganglion blockade in humans. Acta Physiol Scand 2000;170:33-8.
|
| 67. | Ide K, Secher NH. Cerebral blood flow and metabolism during exercise. Prog Neurobiol 2000;61:397-414.
[PUBMED] [FULLTEXT] |
| 68. | Aaslid R, Lindegaard KF, Sorteberg W, Nornes H. Cerebral autoregulation dynamics in humans. Stroke 1989;20:45-52.
[PUBMED] [FULLTEXT] |
[Figure 1], [Figure 2]
| This article has been cited by | | 1 |
Intraarterial Nimodipine Versus Induced Hypertension for Delayed Cerebral Ischemia: A Modified Treatment Protocol |
|
| Miriam Weiss, Walid Albanna, Catharina Conzen-Dilger, Nick Kastenholz, Katharina Seyfried, Hani Ridwan, Martin Wiesmann, Michael Veldeman, Tobias Philip Schmidt, Murad Megjhani, Henna Schulze-Steinen, Hans Clusmann, Marinus Johannes Hermanus Aries, Soojin Park, Gerrit Alexander Schubert | | Stroke. 2022; 53(8): 2607 | | [Pubmed] | [DOI] | | | 2 |
Task-related hemodynamic responses in human early visual cortex are modulated by task difficulty and behavioral performance |
|
| Charlie S Burlingham, Minyoung Ryoo, Zvi N Roth, Saghar Mirbagheri, David J Heeger, Elisha P Merriam | | eLife. 2022; 11 | | [Pubmed] | [DOI] | | | 3 |
Hypothalamic miR-204 Induces Alteration of Heart Electrophysiology and Neurogenic Hypertension by Regulating the Sympathetic Nerve Activity: Potential Role of Microbiota |
|
| Adam Kassan, Karima Ait-Aissa, Modar Kassan | | Cureus. 2021; | | [Pubmed] | [DOI] | | | 4 |
Current Quest in Natural Bioactive Compounds for Alzheimer’s Disease: Multi-Targeted-Designed-Ligand Based Approach with Preclinical and Clinical Based Evidence |
|
| Ashif Iqubal, Syed Obaidur Rahman, Musheer Ahmed, Pratichi Bansal, Md Rafi Haider, Mohammad Kashif Iqubal, Abul Kalam Najmi, Faheem Hyder Pottoo, Syed Ehtaishamul Haque | | Current Drug Targets. 2021; 22(6): 685 | | [Pubmed] | [DOI] | | | 5 |
The Neurovascular Unit: Focus on the Regulation of Arterial Smooth Muscle Cells |
|
| Patrícia Quelhas, Graça Baltazar, Elisa Cairrao | | Current Neurovascular Research. 2020; 16(5): 502 | | [Pubmed] | [DOI] | | | 6 |
Pipamperone Population Pharmacokinetics Related to Effectiveness and Side Effects in Children and Adolescents |
|
| Sanne M. Kloosterboer, Karin M. Egberts, Brenda C. M. de Winter, Teun van Gelder, Manfred Gerlach, Manon H. J. Hillegers, Gwen C. Dieleman, Soma Bahmany, Catrien G. Reichart, Emma van Daalen, Mirjam E. J. Kouijzer, Bram Dierckx, Birgit C. P. Koch | | Clinical Pharmacokinetics. 2020; 59(11): 1393 | | [Pubmed] | [DOI] | | | 7 |
Recent advances in the neurobiology and neuropharmacology of Alzheimer’s disease |
|
| Kushal Kumar, Ashwani Kumar, Richard M. Keegan, Rahul Deshmukh | | Biomedicine & Pharmacotherapy. 2018; 98: 297 | | [Pubmed] | [DOI] | | | 8 |
Developmental Maturation and Alpha-1 Adrenergic Receptors-Mediated Gene Expression Changes in Ovine Middle Cerebral Arteries |
|
| Dipali Goyal, Ravi Goyal | | Scientific Reports. 2018; 8(1) | | [Pubmed] | [DOI] | | | 9 |
Simultaneous fNIRS and thermal infrared imaging during cognitive task reveal autonomic correlates of prefrontal cortex activity |
|
| Paola Pinti, Daniela Cardone, Arcangelo Merla | | Scientific Reports. 2015; 5(1) | | [Pubmed] | [DOI] | | | 10 |
A Sonographic Quantitative Cutoff Value of Cerebral Venous Outflow in Neurologic Diseases: A Blinded Study of 115 Subjects |
|
| L. Monti,E. Menci,P. Piu,S. Leonini,U. Arrigucci,M. Bellini,A. Zandonella,P. Galluzzi,A. Casasco | | American Journal of Neuroradiology. 2014; | | [Pubmed] | [DOI] | | | 11 |
Influence of variations in systemic blood flow and pressure on cerebral and systemic oxygen saturation in cardiopulmonary bypass patients |
|
| A. Moerman,W. Denys,F. De Somer,P. F. Wouters,S. G. De Hert | | British Journal of Anaesthesia. 2013; 111(4): 619 | | [Pubmed] | [DOI] | | | 12 |
Experimental treatment of superior venous congestion during cardiopulmonary bypass |
|
| T. Tovedal,G. Myrdal,O. Jonsson,M. Bergquist,V. Zemgulis,S. Thelin,F. Lennmyr | | European Journal of Cardio-Thoracic Surgery. 2013; 44(3): e239 | | [Pubmed] | [DOI] | |
|
|
|
|
|
|
|
|
